Patents by Inventor Scott E. McGraw

Scott E. McGraw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal delivery of 3,4-diarylchromans
    Patent number: 5935987
    Abstract: Therapeutically effective amounts of a 3,4-diarylchroman can be administered transdermally by incorporation of the 3,4-diarylchroman in a matrix or liquid reservoir patch suitable for transdermal delivery, which matrix or liquid reservoir patch optionally contains hydrophobic and/or hydrophilic vehicle(s).
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: August 10, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Svend Treppendahl, Klaus Snej Jensen, Scott E. McGraw, Helle Weibel
  • Crystalline?-! 3R 4R-trans-7 methoxy 2,2-dimethyl1-3-phenyl 1-4 ?4-12 ?pyrrolidin-1 -Y1!ethoxyl 1!chromane hydrogen fumarate
    Patent number: 5859045
    Abstract: The present invention provides novel crystalline (-)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-?2-(pyrrolidin-1-yl)e thoxy!phenyl}chromane, hydrogen fumarate useful for reducing or preventing bone loss as well as pharmaceutical compositions containing the same. A process for preparing (-)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-?2-(pyrrolidin-1-yl)e thoxy!phenyl}chromane, hydrogen fumarate is described.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: January 12, 1999
    Assignee: Novo Nordisk A/S Novo Alle
    Inventors: Svend Treppendahl, Jensen Snej Klaus, Scott E. McGraw